We are live on ! Find out more
ARKG icon

ARK Genomic Revolution ETF
ARKG

231 hedge funds and large institutions have $613M invested in ARK Genomic Revolution ETF in 2025 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 53 increasing their positions, 62 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 21

16% more capital invested

Capital invested by funds: $528M → $613M (+$85.7M)

8% more funds holding

Funds holding: 213 → 231 (+18)

4.85% more ownership

Funds ownership: 49.93% → 54.79% (+4.9%)

10% less call options, than puts

Call options by funds: $78.8M | Put options by funds: $87.2M

15% less repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 62

Holders
231
Holders Change
+18
Holders Change %
+8.45%
% of All Funds
3.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
42
Increased
53
Reduced
62
Closed
21
Calls
$78.8M
Puts
$87.2M
Net Calls
-$8.44M
Net Calls Change
-$159K

Top Buyers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
+$21.4M
2
Morgan Stanley
Morgan Stanley
New York
+$17.8M
3
Jane Street
Jane Street
New York
+$5.83M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$5.07M
5
KF
Krilogy Financial
Missouri
+$4.93M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$25.9M
2
JP Morgan Chase
JP Morgan Chase
New York
-$10.4M
3
Citadel Advisors
Citadel Advisors
Florida
-$9.64M
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$7.47M
5
UBS Group
UBS Group
Switzerland
-$5.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIM
176
Anchor Investment Management
South Carolina
$8.68K – – –
CLOS
177
Compagnie Lombard Odier SCmA
Switzerland
$8.61K – – –
DFA
178
DHJJ Financial Advisors
Illinois
$8.43K – – –
ACM
179
Anfield Capital Management
California
$8.36K – – –
HI
180
Horizon Investments
North Carolina
$8.33K +$2.53K +100 +50%
ECM
181
EMC Capital Management
Texas
$8K -$2K -79 -22%
T
182
Tidemark
California
$7.7K – – –
SWM
183
Spire Wealth Management
Virginia
$7.03K -$1.39K -55 -18%
CA
184
Clearstead Advisors
Ohio
$5.3K – – –
S
185
SignatureFD
Georgia
$4.67K +$758 +30 +22%
TCA
186
Trifecta Capital Advisors
Illinois
$4.3K – – –
SWA
187
SOA Wealth Advisors
New York
$4.3K – – –
AF
188
Advisornet Financial
Minnesota
$4.17K – – –
TCOT
189
Trust Company of Toledo
Ohio
$4.17K – – –
PNC Financial Services Group
190
PNC Financial Services Group
Pennsylvania
$3.89K -$40.5K -1,604 -92%
APW
191
Aventura Private Wealth
Florida
$3.61K – – –
KFP
192
Kerr Financial Planning
California
$3.26K +$3.03K +120 New
CWM
193
Copia Wealth Management
Oregon
$3.22K +$51 +2 +2%
FFA
194
Frazier Financial Advisors
Ohio
$3.19K – – –
PWA
195
Physician Wealth Advisors
Utah
$3.14K -$5.56K -220 -66%
HNB
196
Hilltop National Bank
Wyoming
$2.78K – – –
WP
197
WealthShield Partners
North Carolina
$2.53K – – –
CIA
198
Cape Investment Advisory
Georgia
$2.5K – – –
WWM
199
Wolff Wiese Magana
California
$2.36K – – –
AWM
200
AE Wealth Management
Kansas
$2.19K – – –
6 7
8
9 10

ARKG Hedge Fund Activity: Q3 2025 in Review

231 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q3 2025, worth a combined $613M — up 16% from $528M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new ARKG positions and 21 closed out — a net gain of 21 holders — while 53 added to existing stakes and 62 trimmed.

The largest buyer was Citigroup, adding an estimated $21.4M. The largest seller was Goldman Sachs, cutting an estimated $25.9M.

  • 231 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q3 2025, up from 213 in Q2 2025.
  • Funds reported $613M of ARK Genomic Revolution ETF stock for Q3 2025, up 16% quarter-over-quarter.
  • 42 funds opened new ARK Genomic Revolution ETF positions in Q3 2025 and 21 closed out, a net change of +21 holders.
  • The largest ARK Genomic Revolution ETF buyer in Q3 2025 was Citigroup, an estimated $21.4M added.
  • The largest ARK Genomic Revolution ETF seller in Q3 2025 was Goldman Sachs, an estimated $25.9M sold.

Based on aggregated 13F filings for Q3 2025.